secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2025-02-11T23:59:59+00:00
Accession:  0001213900-25-012213
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Denali Capital Acquisition Corp. Extends Business Combination Deadline to March 11, 2025
--------------------------------------------------------------------------------

- Deposited $15,036.74 into trust account to extend deadline for completing a business combination by one month.
- Extension moves deadline from February 11, 2025 to March 11, 2025.
- Funding from a convertible promissory note issued to Scilex Holding Company (SCLX) with a principal amount of up to $180,000.
- Note is non-interest bearing, repayable upon business combination or liquidation, and convertible into Class A ordinary shares at $10.00 per share at Scilex's option.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025012213/0001213900-25-012213-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025012213/ea023067101-8k425_denalicap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-012213

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer